Your browser doesn't support javascript.
Cryptococcemia in a patient with COVID-19: A case report.
Khatib, Mohamad Y; Ahmed, Amna A; Shaat, Said B; Mohamed, Ahmed S; Nashwan, Abdulqadir J.
  • Khatib MY; Critical Care Medicine Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
  • Ahmed AA; Critical Care Medicine Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
  • Shaat SB; Critical Care Medicine Department Hamad General Hospital (HGH) Hamad Medical Corporation (HMC) Doha Qatar.
  • Mohamed AS; Critical Care Medicine Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
  • Nashwan AJ; Critical Care Medicine Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Clin Case Rep ; 9(2): 853-855, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-985978
ABSTRACT
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article